News + Filings Transactions
All
All (ex-4s)
10-K
10-Q
8-K
3,4,5
Proxy
Prospectus
Other
|
|
Semigran Marc
|
Create: Alert |
All | News | Filings
| Date Filed | Type | Description |
| 08/18/2023 |
4
| Semigran Marc (Chief Development Officer) has filed a Form 4 on Edgewise Therapeutics, Inc.|
Txns:
| Granted 133,333 options to buy
@ $7.08, valued at
$944k
|
|
| 01/03/2023 |
4
| Semigran Marc (Chief Development Officer) has filed a Form 4 on Edgewise Therapeutics, Inc.|
Txns:
| Granted 300,000 options to buy
@ $8.94, valued at
$2.7M
|
|
| 12/05/2022 |
4
| Semigran Marc (Chief Medical Officer) has filed a Form 4 on Renovacor, Inc.|
Txns:
| Disposed/sold 17,425 shares
@ $0
Granted 35,226 shares
@ $0
Disposed/sold 35,226 shares
@ $0
Disposed/sold 88,991 options
@ $0
Disposed/sold 169,849 options
@ $0
Disposed/sold 34,850 options
@ $0 |
|
| 01/26/2022 |
4
| Semigran Marc (Chief Medical Officer) has filed a Form 4 on Renovacor, Inc.|
Txns:
| Granted 17,425 shares
@ $0
Granted 34,850 options
@ $6.45, valued at
$224.8k
|
|
| 12/22/2021 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 09/08/2021 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 02/12/2019 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 01/09/2019 |
4
| Semigran Marc (Chief Medical Officer) has filed a Form 4 on MyoKardia Inc|
Txns:
| Paid exercise price by delivering 517 shares
@ $44.2552, valued at
$22.9k
|
|
| 01/03/2019 |
4
| Semigran Marc (Chief Medical Officer) has filed a Form 4 on MyoKardia Inc|
Txns:
| Exercised 1,325 restricted stock units
@ $0 |
|
| 12/20/2018 |
4
| Semigran Marc (Chief Medical Officer) has filed a Form 4 on MyoKardia Inc|
Txns:
| Granted 302 shares
@ $42.16, valued at
$12.7k
|
|
| 09/06/2018 |
4
| Semigran Marc (Chief Medical Officer) has filed a Form 4 on MyoKardia Inc|
Txns:
| Sold 41,400 shares
@ $59.4929, valued at
$2.5M
Sold 3,600 shares
@ $60, valued at
$216k
Exercised 41,400 options to buy
@ $15.95, valued at
$660.3k
Exercised 3,600 options to buy
@ $15.95, valued at
$57.4k
|
|
| 06/29/2018 |
4
| Semigran Marc (Chief Medical Officer) has filed a Form 4 on MyoKardia Inc|
Txns:
| Granted 6,250 options to buy
@ $15.95, valued at
$99.7k
|
|
| 01/18/2018 |
4
| Semigran Marc (Chief Medical Officer) has filed a Form 4 on MyoKardia Inc|
Txns:
| Granted 31,800 options to buy
@ $52, valued at
$1.7M
Granted 5,300 restricted stock units
@ $0 |
|
| 12/05/2016 |
4
| Form 4 - Statement of changes in beneficial ownership of securities |
|
|